Oligodendrogenic neural progenitors for treatment of chronic compressive cervical spinal cord injury
Stem Cells Translational Medicine · 2025
DOI: 10.1093/stcltm/szaf047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2025. Verfasst von Zixiang Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, ON M5T 0S8, Canada. Hauptthemen laut MEDLINE: Neural Stem Cells, Spinal Cord Injuries, Oligodendroglia, Spinal Cord Compression. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canada First Research Excellence Fund "Medicine by Design" Pivotal Experiment Fund, Canada First Research Excellence Fund “Medicine by Design” Pivotal Experiment Fund.
Abstract (Originalsprache)
Chronic compressive cervical spinal cord injury (cCSCI), a debilitating condition, lacks effective treatment options. Addressing this gap, our study introduces a novel rat model of cCSCI developed through spinal cord compression via synthetic polyether sheet implantation, closely mimicking human pathology. We evaluated the model’s fidelity utilizing a comprehensive series of behavioral, electrophysiological, and histological assessments. Our research also explored the therapeutic potential of oligodendrogenic neural progenitor cells (oNPCs) derived from induced pluripotent stem cells. Transplanted oNPCs successfully integrated into the host spinal cord, differentiated into neurons, astrocytes, and oligodendrocytes, and demonstrated a remarkable capacity for enhancing neuroplasticity. Electrophysiological analyses revealed significant improvements in motor evoked potentials and a rectification of the excitability imbalance posttransplantation, indicating substantial recovery of motor circuits. Histological findings complemented these results, showing enhanced remyelination and a reduction in excitatory transmitter expression in the residual gray matter. Functionally, the transplantation of oNPCs led to marked improvements in grip strength, locomotor abilities, and sensory functions, surpassing those seen with standard treatments. This study not only provides a novel and reliable rat model of cCSCI for further research but also highlights the potential of oNPCs as a transformative approach for spinal cord injury therapy, suggesting their significant role in neural regeneration and repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Genetics and Development, Krembil Research Institute, University Health Network, Toronto, ON M5T 0S8, Canada.
- Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
- Institute of Medical Science, University of Toronto, Toronto, ON M5S 3K3, Canada.
- Department of Surgery and Spine Program, University of Toronto, Toronto, ON M5T 1P5, Canada.
ORCID-Profile: Michael G Fehlings
Förderung
- Canada First Research Excellence Fund "Medicine by Design" Pivotal Experiment Fund
- Canada First Research Excellence Fund “Medicine by Design” Pivotal Experiment Fund
Zitieren
APA
Luo, Z., Lou, Z., Zavvarian, M. M., Kouhzaei, S., Wang, J., Hong, J., Kim, S. J., Hu, J., Khazaei, M., & Fehlings, M. G. (2025). Oligodendrogenic neural progenitors for treatment of chronic compressive cervical spinal cord injury. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szaf047
Vancouver
Luo Z, Lou Z, Zavvarian MM, Kouhzaei S, Wang J, Hong J, et al. Oligodendrogenic neural progenitors for treatment of chronic compressive cervical spinal cord injury. Stem Cells Translational Medicine. 2025. doi:10.1093/stcltm/szaf047
BibTeX
@article{Luo2025,
author = {Luo, Zixiang and Lou, Zijian and Zavvarian, Mohammad-Masoud and Kouhzaei, Sogolie and Wang, Jian and Hong, James and Kim, Seong Jun and Hu, Jianzhong and Khazaei, Mohamad and Fehlings, Michael G},
title = {Oligodendrogenic neural progenitors for treatment of chronic compressive cervical spinal cord injury},
journal = {Stem Cells Translational Medicine},
year = {2025},
doi = {10.1093/stcltm/szaf047}
}
EUVIMED